Printer Friendly

Browse Antigens topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics. Nov 19, 2014 1613
Affinity Biologicals Inc. Launches Their Debut VisuLize[TM] Factor VII Antigen - A Polyclonal Antibody Based ELISA Kit. Nov 11, 2014 313
Event no. Identification badges 5772/14 antigens hla class 1 and class 2 elisa method. Plate. Nov 10, 2014 114
Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents. Oct 28, 2014 644
Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents. Oct 28, 2014 651
Generex / Antigen Express to Participate in 2014 BIO-Europe Annual International Partnering Conference. Conference news Oct 23, 2014 966
Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip. Oct 22, 2014 480
Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express. Oct 21, 2014 1081
Critical Alerts For BlackBerry, Sears Holdings, ImmunoGen, NPS Pharmaceuticals and Medivation Released By InvestorsObserver. Oct 21, 2014 554
Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene. Oct 15, 2014 1642
Dengue, antigen antibody igg / igm, reagent for determining s / c order 3809/14 quantity 150. Oct 10, 2014 101
Cod.12808 hepatitis b surface antigen, reagent test for determining, prompt delivery, will raise record of failure affect him future purchases, if no accreditation. Oct 10, 2014 128
Cod.12816 hepatitis c antigen, reagent test for determining, prompt delivery, will raise record of failure affect him future purchases, if no account with accreditation. Oct 10, 2014 130
Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine. Oct 7, 2014 977
The impact of blood group antigen discrepancies on today's blood banks. Denomme, Gregory A. Oct 1, 2014 1916
Critical Alerts For Best Buy, Green Dot, Schlumberger, ImmunoGen and Intuitive Surgical Released By InvestorsObserver. Sep 25, 2014 533
ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech. Sep 24, 2014 771
Generex / Antigen Express to Participate in BioPharm America(TM) 2014. Sep 3, 2014 959
3035 order code 12808 hepatitis b surface antigen reagent for the determination of (compatible with equipment cobas e601) number 100. Sep 3, 2014 117
Association between genetic polymorphism in the swine leukocyte antigen-DRA gene and piglet diarrhea in three Chinese pig breeds. Yang, Q.L.; Zhao, S.G.; Wang, D.W.; Feng, Y.; Jiang, T.T.; Huang, X.Y.; Gun, S.B. Report Sep 1, 2014 5599
Comparison of NS1 antigen detection ELISA, real time RT-PCR and virus isolation for rapid diagnosis of dengue infection in acute phase. Ahmed, Nishat Hussain; Broor, Shobha Report Sep 1, 2014 3974
Affinity Biologicals Introduce Upgraded Collection of VisuLize[TM] Antigen ELISA Kits. Aug 21, 2014 355
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte. Aug 21, 2014 1625
Reagent Agreement for HIV/Hepatitis C antibodies and antigens and equipment. Aug 8, 2014 106
Establishment of an antigen bank against fmd. Aug 7, 2014 146
Critical Alerts For Disney, ImmunoGen, Vodafone Group, Toyota Motor, and NASDAQ Released By InvestorsObserver. Aug 4, 2014 535
The Zacks Analyst Blog Highlights: AbbVie, Shire, ARIAD Pharmaceuticals, ImmunoGen and Durata Therapeutics. Aug 1, 2014 2546
Test-System of ELISA (a set of reagents) for simultaneous detection of HIV-1 p24 antigen and antibodies to HIV. Quantity: 439 680 test-systems (research). Jul 22, 2014 130
Review on Biotech Stocks -- Incyte, ACADIA Pharma, Cel-Sci, Aegerion Pharma, and ImmunoGen. Jul 18, 2014 1510
Critical Alerts For Royal Gold, Bed Bath & Beyond, ImmunoGen, ResMed, and Whirlpool Released By InvestorsObserver. Jul 8, 2014 537
Hepatitis b antigen e, reagent for the determination. Test. Jul 2, 2014 104
Hepatitis b surface antigen, reagent for the determination. Jul 2, 2014 101
Event 2661/14. Human immune virus antigen-antibody, reagent for the determination. Jul 2, 2014 104
Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen. Clinical report Jun 25, 2014 1644
Recognitions, Shareholder Meeting Schedules, Partnerships, and Technical Updates - Analyst Notes on WellPoint, Medtronic, Auxilium, Sirona and ImmunoGen. Jun 17, 2014 1455
Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation. Jun 17, 2014 1031
Generex / Antigen Express to Participate in 2014 BIO International Convention. Jun 10, 2014 845
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma. Jun 5, 2014 1386
Launching an Improved Range of Visulize[TM] Antigen ELISA Kits, Affinity Biologicals Inc. Simplifies Quantitative Assays of Hemostasis and Thrombosis-Related Proteins. May 29, 2014 394
Von willebrand factor antigen, reagent for the determination. May 26, 2014 102
Hepatitis b surface antigen, reagent for the determination. May 17, 2014 101
Biotech Stocks on our Radar -- Research on ImmunoGen, Idenix Pharma, Repligen, and Vanda Pharma. May 9, 2014 1410
Oxford BioTherapeutics Takes Exclusive Rights to Use Amgen Xenomouse Antibodies and ImmunoGen Technology to Develop Novel Antibody-Drug Conjugate for HER2-Negative Breast Cancer. May 7, 2014 616
Crp avitex latex antigen pkt of 1 x 50 t. May 7, 2014 101
Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection. Teishima, Jun; Maruyama, Satoshi; Mochizuki, Hideki; Oka, Kiyotaka; Ikeda, Kenichiro; Goto, Keisuke; Report May 1, 2014 3609
Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis. Guo, Aiye; Wang, Xiuhua; Gao, Lan; Shi, Juan; Sun, Changyi; Wan, Zhen Report May 1, 2014 3838
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting. Apr 23, 2014 1102
Pre-Market Scans on Top Gainers -- Research on Athlon Energy, Venaxis, Desarrolladora Homex, and ImmunoGen. Apr 10, 2014 1443
United Kingdom : Update on phase III clinical trial of investigational MAGE-A3 antigen-specific cancer immunotherapeutic in non-small cell lung cancer. Apr 3, 2014 422
Affinity Biologicals Inc. Now Offers a Complete Range of VisuLize[TM] Antigen ELISA Kits for Human Plasma Sample Analysis. Mar 26, 2014 724
Diphtheria, tetanus, pertussis (acellular, complex) adsorbed, with reduced antigen content. Mar 24, 2014 157
United Kingdom : Investigational MAGE-A3 antigen-specific cancer immunotherapeutic does not meet first co-primary endpoints in MAGRIT, a phase III non-small cell lung cancer clinical trial. Mar 21, 2014 379
Ern laboratory - march - microbiology reagents (gn ident, bordetella, kovac reagent, latex, antigen, fuchsin, amikacin, cefepime, filament, stuart transport tubes, vdrl antigen, sensidiscs). Mar 8, 2014 106
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza. Mar 5, 2014 827
Effects of ejaculation on serum prostate-specific antigen levels: ejakualasyonun serum prostat spesifik antijen duzeylerine etkisi. Demir, Kadir; Tarhan, Fatih; Orcun, Asuman; Asian, Hasan; Turk, Akif Report Mar 1, 2014 4542
Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients. Feb 27, 2014 960
Delivery of microbiological tests and substrates; latex tests, tests for the detection of antigens in stool and serum. Feb 22, 2014 134
Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial. Feb 12, 2014 1150
Human immune deficiency virus antigen , antibody , reagent for the determination code 13811 request 89/14 quantity 2100. Feb 4, 2014 110
Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA. Sprenkle, Mark D.; Griffith, Jayne; Marinelli, William; Boyer, Anne E.; Quinn, Conrad P.; Pesik, Nic Feb 1, 2014 2921
ArcDia Launches World's First Antigen Test for Human Bocavirus. Jan 20, 2014 532
ArcDia Launches World's First Antigen Test for Human Bocavirus. Jan 20, 2014 538
Critical Alerts For AT&T, Gold SPDR, Arrowhead Research, Johnson & Johnson, and ImmunoGen Released By InvestorsObserver. Jan 14, 2014 462
Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial. Jan 13, 2014 1070
Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference. Conference news Jan 9, 2014 1096
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen. Conference news Jan 7, 2014 1428
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Boulware, David R.; Rolfes, Melissa A.; Rajasingham, Radha; von Hohenberg, Maximilian; Qin, Zhenpeng Jan 1, 2014 6531
United States : IMMUNOGEN gets new CFO. Dec 31, 2013 147
Heptares Highlights Potential of StaR Proteins as Antigens for GPCR-Targeted Antibody Discovery in New Scientific Publication. Dec 16, 2013 585
Heptares Highlights Potential of StaR Proteins as Antigens for GPCR-Targeted Antibody Discovery in New Scientific Publication. Dec 16, 2013 590
Investor Meetings, New Clinical Data, Closing of Offering, and New Programs - Research Report on Teleflex, Orexigen, Sangamo, InterMune, and ImmunoGen. Report Dec 13, 2013 1596
Critical Alerts For SPDR Gold, ImmunoGen, JA Solar, Shire, and Gray Television Released By InvestorsObserver. Dec 13, 2013 459
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax. Report Dec 5, 2013 1393
Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Dec 1, 2013 321
Enhancement of antigen-specific immunoglobulin g production in mice by co-administration of L-cystine and L-theanine. Dec 1, 2013 236
Feeding the immune system. Dec 1, 2013 257
Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen. Report Nov 21, 2013 1357
Antigen Express AE37 Breast Cancer Vaccine Update. Nov 18, 2013 1009
Public Offerings, Clinical Tests, and Financial Results- Research Report on InterMune, Emergent BioSolutions, ImmunoGen, Sequenom, and Intrexon. Report Nov 13, 2013 1606
Critical Alerts For Anheuser-Busch InBev, JA Solar, Rackspace Hosting, ImmunoGen, and Gray Television Released By InvestorsObserver. Nov 12, 2013 460
United States : PARAGON BIOSERVICES secures contract from PFENEX for cGMP manufacturing of its Recombinant Protective Antigen (rPA) based anthrax vaccine. Nov 7, 2013 185
Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine. Nov 5, 2013 416
The effects of cigarette smoking on prostate-specific antigen in two different age groups. Koc, Gokhan; Akgul, Korhan; Yilmaz, Yuksel; Dirik, Alper; Un, Sitki Clinical report Nov 1, 2013 2926
Alpha-fetoprotein and carbohydrate antigen 19-9 producing advanced adenocarcinoma of renal pelvis and ureter. Yang, Kai; Zheng, Xiang-Yi; Wang, Yan-Li; Zhao, Kui; Jiang, Hai Case study Nov 1, 2013 1670
Contract Awarded to develop a robust, scalable, cGMP-ready production process for large-scale production of the blood-stage malaria antigen Plasmodium falciparum reticulocyte-binding homolog 5 (Rh5). Oct 30, 2013 173
Pfenex Inc. awarded a subcontract by Leidos to develop a scalable cGMP production process for a second key malaria antigen. Oct 29, 2013 492
First rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies now available. Oct 29, 2013 598
Cancer Network and journal ONCOLOGY Highlight Prostate-Specific Antigen (PSA) Screening. Oct 28, 2013 678
Yelp, Crocs, ImmunoGen, Sanofi and Eli Lilly highlighted as Zacks Bull and Bear of the Day. Oct 22, 2013 2685
United Kingdom,United States : NOVARTIS inks new license agreement with ImmunoGen for ADC technology. Oct 14, 2013 140
Ern laboratory - october microbiology reagents (vdrl antigen, meningites kit, clostridium difficile, sensidiscs) / / ll1. Oct 10, 2013 108
Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen. Report Oct 7, 2013 1488
FRANCE - Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis. (MYASTERIX). Oct 3, 2013 339
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine. Oct 1, 2013 435
Critical Alerts For Facebook, HanesBrands, SodaStream, and ImmunoGen Released By InvestorsObserver. Sep 12, 2013 454
Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA. Report Sep 3, 2013 1439
Bio Farma Launches Pentavalent Vaccine, Combining Five Antigens. Aug 24, 2013 564
Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy. Aug 13, 2013 1043
Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board. Aug 12, 2013 767
United States : FDA approves first rapid diagnostic test to detect both HIV-1 antigen and HIV-1/2 antibodies. Aug 10, 2013 394
Critical Alerts For SunPower, Boston Properties, T-Mobile, ImmunoGen, and Santarus Released By InvestorsObserver. Aug 8, 2013 455
Collaborations, Global Platforms, and Strong Sales Drive Revenue Growth - Research Report on Baxter, Mylan, ImmunoGen, Emeritus, and Synta. Report Aug 7, 2013 1630
Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board. Jul 23, 2013 1207
Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board. Jul 12, 2013 1348
Generex Announces Conference Call with Members of the Antigen Express Scientific Advisory Board. Jul 1, 2013 829
Antigen microarrays for the study of autoimmune diseases. Yeste, Ada; Quintana, Francisco J. Report Jul 1, 2013 6398
Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen. Clinical report Jun 14, 2013 1635
Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine. May 22, 2013 1134
Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response. May 8, 2013 816
The recombinant hepatitis b surface antigen vaccine in persons with HIV: is seroconversion sufficient for long-term protection? Brief article May 1, 2013 116
Critical Alerts For American International Group, Bunge, Cliffs Natural Resources, Amarin, and ImmunoGen Released By InvestorsObserver. Apr 29, 2013 486
Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences. Apr 15, 2013 279
Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2. Mar 18, 2013 627
iBio Adds to iBioModulator Portfolio and Product Pipeline. Mar 13, 2013 961
A systematic review: sensitivity and specificity of a new cryptococcal antigen lateral flow assay in serum and cerebrospinal fluid. Klausner, Jeffrey D.; Vijayan, Tara; Chiller, Tom Report Mar 1, 2013 1841
Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role? Jackson, Brian R. Clinical report Mar 1, 2013 1056
Role of minor erythrocyte antigens on alloimmunization in neonatal indirect hyperbilirubinemia background/Indirekt hiperbilirubinemili olgularda minor eritrosit antijenlerinin alloimmunizasyondaki rolu. Orgun, Ali; Calkavur, Sebnem; Olukman, Ozgur; Tekin, Leman; Kilic, Fatma Kaya; Ayhan, Yuce; Vergin, Report Mar 1, 2013 4820
Critical Alerts For General Motors, Best Buy, AutoZone, Crocs, and ImmunoGen Released By InvestorsObserver. Feb 25, 2013 484
ImmunoGen, Inc. Announces FDA Approval of Kadcyla (Ado-Trastuzumab Emtansine; Also Known as T-DM1). Feb 22, 2013 979
2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers. Industry overview Feb 13, 2013 1207
ImmunoGen, Inc. Attains Patient Enrollment Milestone in IMGN901 NORTH Trial. Feb 12, 2013 876
United Kingdom : Studies on antigen presentation and immune recognition in hsp transfected tumor cells. Feb 8, 2013 168
Generex Touts Pipeline Potential of Antigen Express Subsidiary. Feb 7, 2013 1165
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news Feb 5, 2013 364
Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine. Jan 31, 2013 1160
Research and Markets: Standards for Molecular Testing for Red Cell, Platelet and Neutrophil Antigens, 1st Edition Includes the MT Standards on CD-ROM. Jan 28, 2013 339
Critical Alerts For Wal-Mart, State Street, HollyFrontier, Tyson Foods, and ImmunoGen Released By InvestorsObserver. Jan 22, 2013 484
Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview. Jan 17, 2013 970
Positive Interim Safety Analysis Achieved in Breast Cancer Patients Treated with HER2/neu Antigens. Jan 9, 2013 643
ImmunoGen, Inc. Announces Webcast of Presentation at the 31st Annual J.P. Morgan Healthcare Conference. Conference news Jan 2, 2013 275
Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. Jan 1, 2013 8201
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Stephan, Carsten; Jung, Klaus; Semjonow, Axel; Schulze-Forster, Kai; Cammann, Henning; Hu, Xinhai; M Report Jan 1, 2013 6435
Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer. Stephan, Carsten; Vincendeau, Sebastien; Houlgatte, Alain; Cammann, Henning; Jung, Klaus; Semjonow, Report Jan 1, 2013 6544
Amgen Takes Third License for Rights to Use ImmunoGen's TAP Technology. Dec 19, 2012 343
ImmunoGen, Inc. Announces IMGN901 Clinical Data Presented at ASH. Clinical report Dec 10, 2012 968
ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 23rd Annual Healthcare Conference. Conference news Dec 6, 2012 250
ImmunoGen, Inc. Announces Clinical Data Presentations at the 54th ASH Annual Meeting and Exposition. Dec 3, 2012 635
Virulent avian infectious bronchitis virus, People's Republic of China. Feng, Jinling; Hu, Yanxin; Ma, Zhijun; Yu, Qi; Zhao, Jixun; Liu, Xiaodong; Zhang, Guozhong Dec 1, 2012 4614
The PSA controversy: part I. Strum, Stephen B. Report Dec 1, 2012 5081
Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Abstract Dec 1, 2012 321
Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta's Synthetic Vaccine Particle Technology. Nov 28, 2012 804
Promising Data Presented on GenVec Malaria Program. Conference notes Nov 14, 2012 1094
ImmunoGen, Inc. Announces FDA Has Granted Priority Review Status to the Trastuzumab Emtansine (T-DM1) Marketing Application. Nov 6, 2012 404
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news Nov 5, 2012 317
Celldex Therapeutics Makes Significant Advancements in the Field of Protein-Based Vaccine Development. Oct 29, 2012 1464
Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen. Oct 24, 2012 609
Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine. Oct 17, 2012 387
Inovio Pharmaceuticals' Cancer Vaccine Demonstrates for 1st Time that a DNA-Based Therapeutic Vaccine Can Produce Immune Responses to Kill Target Cells. Oct 10, 2012 1945
Research and Markets: ImmunoGen, Inc. - Product Pipeline Review - 2012. Company overview Oct 8, 2012 367
Zacks Bull and Bear of the Day Highlights: Discover Financial Services, Scientific Games, Roche Holdings, GlaxoSmithKline and ImmunoGen. Oct 3, 2012 1714
ImmunoGen, Inc. Announces Overall Survival Data Reported for Trastuzumab Emtansine (T-DM1) Phase III EMILIA Trial. Oct 1, 2012 915
Novel Malaria Vaccine Collaboration Announced by Protein Potential LLC and Aduro BioTech Inc. Sep 19, 2012 646
ImmunoGen, Inc. Announces Presentation of New IMGN901 Clinical Data. Sep 6, 2012 1359
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news Sep 4, 2012 356
ImmunoGen, Inc. Announces Trastuzumab Emtansine (T-DM1) Significantly Improved Survival in the EMILIA Phase III Trial. Clinical report Aug 27, 2012 840
Alnylam and Collaborators Publish New Pre-clinical Results on Ex Vivo Applications of RNAi to Enhance Dendritic Cell Vaccines for Cancer. Aug 22, 2012 1630
Genocea Initiates a Phase 1/2a Study with Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2). Report Aug 15, 2012 846
Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device. Aug 15, 2012 568
Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria. Aug 13, 2012 630
Genocea Unveils Protective Therapeutic Vaccine for Herpes Simplex Virus Type 2 (HSV-2). Aug 5, 2012 1102
Critical Trade Alerts For Ford, Valero, Humana, Sourcefire, and ImmunoGen Released By InvestorsObserver. Aug 1, 2012 485
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Brief article Aug 1, 2012 264
ImmunoGen, Inc. Prices Public Offering of Common Stock. Jul 12, 2012 625
ImmunoGen, Inc. Initiates Phase I Trial of IMGN853 in Ovarian Cancer and Other Solid Tumors Over-Expressing Its Folate Receptor Target. Jul 11, 2012 838
ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. Jul 11, 2012 555
Generex Announces Results of Annual Stockholders' Meeting. Jun 20, 2012 1599
Advaxis ADXS-PSA Construct Causes Significant Tumor Regression in Preclinical Prostate Cancer Study. Jun 13, 2012 1055
Genocea Announces New Research Identifying Potential Vaccine Candidates for Chlamydia. Jun 7, 2012 791
Generex Announces ASCO 2012 Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology. Jun 6, 2012 1122
ImmunoGen, Inc. Announces Development of Trastuzumab Emtansine for Early Stage HER2-Positive Breast Cancer. Jun 4, 2012 583
ImmunoGen, Inc. Announces Presentation of New Clinical Data for SAR3419. Jun 4, 2012 740
Polynoma Commences Phase III Melanoma Vaccine Clinical Trial. Clinical report Jun 4, 2012 893
ImmunoGen, Inc. Announces Results from Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial. Jun 3, 2012 942
Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostate. Venkateswaran, Seetha; Margel, David; Yap, Stanley; Hersey, Karen; Yip, Paul; Fleshner, Neil Eric Clinical report Jun 1, 2012 2565
Immunological characterisation of an unmasking TB-IRIS case. Wilkinson, Katalin A.; Meintjes, Graeme; Seldon, Ronnett; Goliath, Rene; Wilkinson, Robert J. Report Jun 1, 2012 4245
Circulation of dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. Gupta, Ekta; Mohan, Sweta; Bajpai, Meenu; Choudhary, Aashish; Singh, Gaurav Report Jun 1, 2012 2287
Diagnostic role of anti-nuclear antibodies in rheumatic diseases / romatizmal hastaliklarda antInukleer antIkorlarin tanisal rolu. Birtane, Murat Disease/Disorder overview Jun 1, 2012 6233
S&P Capital IQ Initiates Coverage on Medicago Inc. in Standard & Poor's Factual Stock Reports. May 31, 2012 917
Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine. May 17, 2012 1204
ImmunoGen, Inc. Announces Presentations at 2012 ASCO Annual Meeting on Product Candidates with the Company's TAP Technology. May 16, 2012 805
Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers. May 15, 2012 1244
Broad Patent Protection Granted for iBio Immunomodulator. May 8, 2012 1114
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news May 8, 2012 297
Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Petersen, Randi Fons; Dalby, Tine; Dragsted, Ditte Marie; Mooi, Frits; Lambertsen, Lotte May 1, 2012 4740
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine. May 1, 2012 366
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its Novel IMGN529 Anticancer Compound. Apr 17, 2012 802
ImmunoGen, Inc. Announces the IND Is Now Active for Its Folate-Receptor Targeting Anticancer Compound, IMGN853. Apr 17, 2012 622
Novel T Cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine. Apr 11, 2012 598
Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer. Conference news Apr 3, 2012 1183
Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology. McDermed, Jonathan E.; Sanders, Ron; Fait, Stephen; Klem, Robert E.; Sarno, Mark J.; Adams, Thomas H Report Apr 1, 2012 5531
Sublingual immunotherapy an alternative to allergy shots. Saporta, Diego Apr 1, 2012 4652
Performance of the BMD FIDIS[TM]Connective 10[R] ENA luminex method in external quality assurance proficiency programmes in a diagnostic laboratory setting. Austin, Paul M.; Thompson, Helena T.; Brown, Anthony R. Report Apr 1, 2012 3688
Pre-treatment risk stratification of prostate cancer patients: A critical review. Rodrigues, George; Warde, Padraig; Pickles, Tom; Crook, Juanita; Brundage, Michael; Souhami, Luis; L Report Apr 1, 2012 5928
ImmunoGen, Inc. Announces Positive Results in Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial. Mar 30, 2012 864
ImmunoGen, Inc. Announces Conference Call at 8:00 am ET March 30, 2012 to Discuss Today's Favorable Announcements about Trastuzumab Emtansine (T-DM1) and about IMGN901. Mar 30, 2012 287
ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate. Mar 30, 2012 1025
GenVec Awarded Grant for Antigen Discovery Project. Mar 26, 2012 698
Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine. Clinical report Mar 14, 2012 1075
ImmunoGen, Inc. Announces Webcast of Presentation at the Cowen 32nd Annual Health Care Conference. Conference news Mar 2, 2012 244
Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. M'ikanatha, Nkuchia M.; Dettinger, Lisa A.; Perry, Amanda; Rogers, Paul; Reynolds, Stanley M.; Nacha Report Mar 1, 2012 2795
ImmunoGen, Inc. Adds Two New Directors to the Board. Mar 1, 2012 408
ImmunoCellular Therapeutics Licenses Mesothelin Cancer Antigen from Johns Hopkins University. Feb 29, 2012 547
Generex Subsidiary Antigen Express to Present at Prestigious Cancer Immunotherapy Summit. Feb 27, 2012 1157
Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy. Jan 17, 2012 1494
Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference. Conference news Jan 5, 2012 1174
Generex Subsidiary Antigen Express Available for Partnering & Collaboration Meetings at the 2012 JPMorgan Healthcare Conference. Conference news Jan 4, 2012 990
Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccine's Clinical & Regulatory Strategy. Jan 3, 2012 1585
The exposure immunogenic protein of viral nervous necrotic on Humpback grouper that influences to proliferation and expression of immune cells (interferon [gamma] and NF-Kb cell). Yanuhar, Uun; Gusman, Ery; Arfiati, Diana Report Jan 1, 2012 5329
Accelerating control of pertussis in England and Wales. Campbell, Helen; Amirthalingam, Gayatri; Andrews, Nick; Fry, Norman K.; George, Robert C.; Harrison, Clinical report Jan 1, 2012 7317
Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television. Dec 21, 2011 723
Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today. Clinical report Dec 19, 2011 1018
Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television. Clinical report Dec 14, 2011 1209
NanoBio[R] to Collaborate in Research Effort for Respiratory Syncytial Virus Vaccine With Merck. Dec 8, 2011 520
The association between tumour density and prostate cancer recurrence following radical prostatectomy. Lavallee, Luke T.; Breau, Rodney H.; Preston, Mark A.; Raju, Gayanna; Morash, Christopher; Doucette, Report Dec 1, 2011 2850
Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. Ahuka-Mundeke, Steve; Ayouba, Ahidjo; Mbala-Kingebeni, Placide; Liegeois, Florian; Esteban, Amandine Report Dec 1, 2011 6908
Preliminary characterization of N-trimethylchitosan as a nanocarrier for malaria vaccine. Nnamani, P.O.; Scoles, G.; Krol, S. Clinical report Dec 1, 2011 2379
Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen. Nov 28, 2011 758
Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen. Nov 28, 2011 762
ImmunoCellular Therapeutics to Present at the 16th Annual Meeting of the Society for Neuro-Oncology. Nov 18, 2011 627
Advaxis Licenses Novel Antigen for Severe Breast Cancer and Other Tumor Types. Nov 15, 2011 615
Ajuga remota benth.: from ethnopharmacology to phytomedical perspective in the treatment of malaria. Cocquyt, K.; Cos, P.; Herdewijn, P.; Maes, L.; Van den Steen, P.E.; Laekeman, G. Report Nov 15, 2011 7465
Common variable immunodeficiency (CVID); a case study. Christian, Christian Report Nov 1, 2011 2788
Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme. Wernicke, A. Gabriella; Edgar, Mark A.; Lavi, Ehud; Liu, He; Salerno, Pamela; Bander, Neil H.; Gutin Disease/Disorder overview Nov 1, 2011 2586
Research and Markets: Vaccines in Clinical Trials: Cancer - 12 Fascinating Review-Length Articles. Oct 11, 2011 397
Research and Markets: Vaccines in Clinical Trials: Infectious Diseases. Oct 11, 2011 401
Research and Markets: Lung Cancer Vaccines: 2011 Pipeline, Strategies and Clinical. Clinical report Oct 11, 2011 530
Research and Markets: Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical. Oct 7, 2011 503
Dietary vitamin E influences the levels of nitric oxide and cytokines in broiler chickens. Xu, Jian-xiong; Chen, Xiao-lian; Wang, Jing; Wang, Tian Report Sep 28, 2011 5523
DePEGylation studies: PEG-RBC stability in conditions consistent with massive transfusion. Moore, M. Scott; Okelberry, Eric; Cordingley, Krystle; Drake, Alex; Robinett, Zachary Report Sep 22, 2011 3096
Antigen Express' AE37 Cancer Vaccine Featured in Scientific American. Sep 21, 2011 1234
Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy. Sep 19, 2011 1414
Inovio Pharmaceuticals Completes PENNVAX(TM)-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses. Sep 14, 2011 1735
ProImmune Introduces ProPresent Assay for Measurement of Antigen Processing and Presentation. Sep 8, 2011 398
IDRI, USAID Strike New Collaboration for Malaria Vaccine Development. Aug 16, 2011 781
ImmunoGen, Inc. Announces Webcast of Presentation at the Canaccord Genuity 31st Annual Growth Conference. Conference news Aug 5, 2011 250
NanoBio[R] Secures Novel Antigen Source for its Intranasal RSV Vaccine. Aug 3, 2011 690
Translating medical evidence to promote informed health care decisions. McCormack, Lauren; Treiman, Katherine; Bann, Carla; Williams-Piehota, Pamela; Driscoll, David; Poehl Aug 1, 2011 8359
PharmAthene's rPA Anthrax Vaccine Program Demonstrates 36 Month Product Stability. Jul 12, 2011 959
Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology. Jul 11, 2011 1324
Epidemiology and control of legionellosis, Singapore. Lam, Meng Chon; Ang, Li Wei; Tan, Ai Ling; James, Lyn; Goh, Kee Tai Report Jul 1, 2011 5273
Citrus pectin. Report Jul 1, 2011 2791
Scancell Develops New Vaccine for the Treatment of Lung Cancer. Jun 30, 2011 797
SCANCELL HOLDINGS PLC - Development of new vaccine for treating lung cancer. Jun 30, 2011 842
ImmunoCellular Therapeutics to Present at 2nd World Cancer Vaccines Summit. Jun 22, 2011 748
Autoimmune disease: what we do and don't know and how Western medical herbalists can help. Harris, Kathy Report Jun 22, 2011 4036
Mintz Levin Represents ImmunoGen, Inc. and Targacept, Inc. in Public Offerings Totaling Approximately $170 Million. Jun 14, 2011 188
ImmunoGen, Inc. Earns Milestone with BAY 94-9343 IND Submission. Jun 14, 2011 567
OncoSec ElectroImmunotherapy Shows Systemic Effects of Metastatic Melanoma Tumor in More than 50% of Patients. Jun 7, 2011 1341
ImmunoGen, Inc. Announces Positive Clinical Data Presented on IMGN901 in the Treatment of Multiple Myeloma. Jun 5, 2011 898
ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference. Conference news Jun 1, 2011 255
Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis. Ohyama, Kaname; Ueki, Yukitaka; Kawakami, Atsushi; Kishikawa, Naoya; Tamai, Mami; Osaki, Makoto; Kam Jun 1, 2011 3021
ImmunoGen, Inc. Announces Clinical Presentations at the ASCO 2011 Annual Meeting. May 26, 2011 714
iBio Announces Successful Production of Critical Hookworm Vaccine Antigen. May 26, 2011 984
ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011. May 24, 2011 828
ImmunoGen, Inc. Prices Public Offering of Common Stock. May 20, 2011 588
ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. May 19, 2011 538
Article in Current Opinion in Immunology Journal Declares Coming "Decade of DNA Vaccines". May 5, 2011 1510
Consortium Awards $23.4 Million for Promising HIV/AIDS Preventive Vaccine Candidate Developed by Institute of Human Virology at the University of Maryland School of Medicine. May 5, 2011 1123
ImmunoGen, Inc. Announces Webcast of Presentation at Bank of America Merrill Lynch 2011 Health Care Conference. Conference news May 3, 2011 261
Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes. May 3, 2011 1045
Adoptive cell transfer targets new cancer antigen. McBride, Deborah May 1, 2011 444
Identification of immunogenic relevant antigens in the excretory-secretory (ES) products of Ascaridia galli larvae. Garedaghi, Yaghoob Report May 1, 2011 2638
Germline sequence variants and prostate-specific antigen interpretation. Loeb, Stacy May 1, 2011 1420
Increased levels of nuclear factor [kappa]B and Fos-related antigen 1 in lung tissues from patients with acute respiratory distress syndrome. Fudala, Rafal; Allen, Timothy Craig; Krupa, Agnieszka; Cagle, Philip T.; Nash, Sandra; Gryczynski, Z May 1, 2011 3739
NanoBio[R] Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan. Apr 20, 2011 624
Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer. Apr 18, 2011 853
Cross-town rivalry; Two companies vie to create cancer vaccine. Apr 17, 2011 1135
T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial. Apr 7, 2011 618
Immunogen Shares Hit New High on Breast Cancer Study Results. Apr 7, 2011 423
ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas. Apr 4, 2011 865
ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin's Lymphoma. Apr 4, 2011 1275
Management of HIV-hepatitis B co-infection: Southern African HIV Clinicians Society. Apr 1, 2011 5542
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? Jarvis, Joseph N.; Harrison, Thomas S.; Govender, Nelesh; Lawn, Stephen D.; Longley, Nicky; Bicanic, Report Apr 1, 2011 2766
Generex Unveils Strategic Development Plan. Mar 30, 2011 2881
ImmunoGen, Inc. Announces Presentations at the 102nd Annual Meeting of the American Association for Cancer Research. Mar 30, 2011 864
An integrated justice model of wrongful convictions. Zalman, Marvin Mar 22, 2011 26701
PCR-based evaluation of tuberculous endometritis in infertile women of North India. Kohli, Monika D.; Nambam, Bimota; Trivedi, Sagar S.; Sherwal, Banke L.; Arora, Sarika; Jain, Anju Report Mar 1, 2011 3096
Tap: novel targets for cancer vaccine development. Wilson, Glynn Mar 1, 2011 2089
Effects of the combined stress induced by stocking density and feed restriction on hematological and cytokine parameters as stress indicators in laying hens. Kang, Sun-Young; Ko, Young-Hyun; Moon, Yang-Soo; Sohn, Sea-Hwan; Jang, In-Surk Report Mar 1, 2011 4395
Report of increased number of children with parapneumonic empyema as a complication of bacterial pneumonia in West Virginia in 2005. Moffett, Kathyrn; Tantoco, Ann-Marie Report Mar 1, 2011 3344
Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals. Frawley, Rachel; White, Kimber, Jr.; Brown, Ronnetta; Musgrove, Deborah; Walker, Nigel; Germolec, Do Report Mar 1, 2011 7183
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news Feb 28, 2011 306
Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd[R] Antigen Based Therapy for Type 1 Diabetes. Clinical report Feb 14, 2011 908
ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. Conference news Feb 8, 2011 306
Inovio Pharmaceuticals' Dual-Antigen SynCon(TM) DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial. Feb 2, 2011 1389
ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2011. Feb 1, 2011 268
Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim[TM]) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. Madhi, Shabir Ahmed; Cutland, Clare; Jones, Stephanie; Groome, Michelle; Ortiz, Esteban Report Feb 1, 2011 5045
Pfenex Inc. Awarded Sub-contract by Science Applications International Corporation (SAIC) to Help Develop a Scalable Production Process Based on Pfenex Expression Technology(TM) for a Key Malaria Antigen. Jan 26, 2011 328
Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. Wang, Hui; Ye, Yan; Pan, Si-Yuan; Zhu, Guo-Yuan; Li, Ying-Wei; Fong, David W.F.; Yu, Zhi-Ling Report Jan 15, 2011 5971
PharmAthene Presents New Anthrax Data at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day. Jan 13, 2011 1518
ImmunoGen, Inc. Announces Webcast of Presentation at J.P. Morgan 29th Annual Healthcare Conference. Conference news Jan 3, 2011 276
Particle Sciences Develops Wax Nanoparticles that Enhance Immune Response to Antigens. Dec 22, 2010 396
Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways. Shyur, Lie-Fen; Lee, Shu-Hua; Chang, Shang-Tzen; Lo, Chiu-Ping; Kuo, Yueh-Hsiung; Wang, Sheng-Yang Report Dec 15, 2010 5620
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer. Dec 10, 2010 998
ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multiple Myeloma. Clinical report Dec 4, 2010 1094
Markers of inflammation, endothelial activation and autoimmunity in adolescent female gymnasts. Alshammari, Eyad; Shafi, Shahida; Nurmi-Lawton, Jaana; Burut, Dayangku Fatiha Pengiran; Lanham-New, Report Dec 1, 2010 7183
Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-[alpha]-induced E-selectin expression by cultured umbilical vein endothelial cells. Takada, K.; T.; Nakane; K.; Masuda; Ishii, H. Report Dec 1, 2010 4381
Today's lab-testing methodologies. Flaws, Maribeth Laude Dec 1, 2010 1383
ImmunoGen, Inc. Announces Initiation of Randomized Clinical Trial Evaluating IMGN901 for First-Line Treatment of Small-Cell Lung Cancer. Nov 30, 2010 763
Soligenix Announces Issuance of United States Patent for RiVax(TM), its Vaccine Against Ricin Toxin. Nov 22, 2010 1652

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters